A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Conditions: Advanced or Metastatic Breast Cancer Interventions: Drug: PF-07220060; Drug: Fulvestrant; Drug: Everolimus; Drug: Exemestane Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Effect of Performance-specific Cleft Speech Intervention and Long-term Learning in Children With a Cleft Palate
Conditions: Cleft Palate Children; Speech Disorders in Children; Cleft Lip and Palate; Speech Therapy Interventions: Behavioral: Motor-phonetic intervention; Behavioral: Phonological intervention; Behavioral: Combined phonetic-phonological intervention Sponsors: University Ghent; Research Foundation Flanders Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants
Conditions: Migraine Interventions: Combination Product: Zavegepant 10 mg; Combination Product: Placebo - Control 1; Combination Product: Placebo - Control 2 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Management of Shoulder Dystocia in Flipped Learning
Conditions: Shoulder Dystocia - Delivered Interventions: Other: flipped learning training group Sponsors: Karabuk University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV
Conditions: Respiratory Syncytial Virus Infections Interventions: Drug: Placebo; Drug: Active Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Deep Learning Algorithm for Detecting Obstructive Coronary Artery Disease Using Fundus Photographs
Conditions: Coronary Artery Disease; Artificial Heart Device User Interventions: Diagnostic Test: coronary artery imaging (coronary CTA or coronary angiography) Sponsors: Yong Zeng Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Compared to Rituximab and Chemotherapy in Adult Participants With Previously Untreated Follicular Lymphoma
Conditions: Follicular Lymphoma (FL) Interventions: Drug: Odronextamab; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone/Prenisolone Sponsors: Regeneron Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials
Learning Curve of Robotic Pancreatoduodenectomy
Conditions: Pancreaticoduodenectomy Interventions: Other: Different phase of the learning curve of RPD Sponsors: Peking Union Medical College Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging
Conditions: Prostate Cancer Interventions: Other: MR prostate exam Sponsors: Centre Hospitalier Universitaire, Amiens Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer Interventions: Other: develop and validate a deep learning radiomics model based on preoperative enhanced CT image Sponsors: First Affiliated Hospital of Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Does Teaching Before or After Simulation Improve Learning?
Conditions: Medical Education; Simulation Interventions: Other: Simulation on Pediatric Status Epilepticus; Other: Didactic Lecture on Pediatric Status Epilepticus Sponsors: University of British Columbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Trial to Learn if Odronextamab is Safe and Well-tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma
Conditions: Follicular Lymphoma (FL) Interventions: Drug: Odronextamab; Drug: Rituximab; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone/prednisolone; Drug: Bendamustine Sponsors: Regeneron Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Palliative Care Health Literacy Education and QOL Compared to Usual Care
Conditions: COPD Interventions: Behavioral: Get Palliative Care: four educational learning module videos Sponsors: University of Missouri, Kansas City Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Conditions: Predictive Ability of Contrast-enhanced CT-based Deep Learning Model in Patients With Localised ccRCC; Generalisation of a Deep Learning Prediction Model in Multicentre Data; Comparison of Prediction Performance Between Deep Learning Prediction Model and Traditional Prediction Models Sponsors: Mingzhao Xiao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Patient Centered Machine Learning Model for Bleeding and Ischemic Risk
Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention Interventions: Device: Percutaneous coronary intervention Sponsors: Abbott Medical Devices; Icahn School of Medicine at Mount Sinai Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
